Literature DB >> 20193633

Vaccines and autoimmune diseases of the adult.

Hedi Orbach1, Nancy Agmon-Levin, Gisele Zandman-Goddard.   

Abstract

Infectious agents contribute to the environmental factors involved in the development of autoimmune diseases possibly through molecular mimicry mechanisms. Hence, it is feasible that vaccinations may also contribute to the mosaic of autoimmunity. Evidence for the association of vaccinations and the development of these diseases is presented in this review. Infrequently reported post-vaccination autoimmune diseases include systemic lupus erythematosus, rheumatoid arthritis, inflammatory myopathies, multiple sclerosis, Guillain-Barré syndrome, and vasculitis. In addition, we will discuss macrophagic myofasciitis, aluminum containing vaccines, and the recent evidence for autoimmunity following the use of human papillomavirus vaccine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20193633

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  14 in total

Review 1.  Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the pediatric background.

Authors:  Susanna Esposito; Elisabetta Prada; Maria Vincenza Mastrolia; Giusyda Tarantino; Claudio Codecà; Donato Rigante
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Evaluation of optic neuritis following human papillomavirus vaccination.

Authors:  Gayathri Sridhar; Fang Tian; Richard Forshee; Martin Kulldorff; Nandini Selvam; Andrea Sutherland; Wilson Bryan; Samuel Barone; Lei Xu; Hector S Izurieta
Journal:  Hum Vaccin Immunother       Date:  2017-05-02       Impact factor: 3.452

3.  Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus.

Authors:  E S Vista; S R Crowe; L F Thompson; G M Air; J M Robertson; J M Guthridge; J A James
Journal:  Lupus       Date:  2012-02       Impact factor: 2.911

4.  Association between Human Papilloma Virus (HPV) vaccination and risk of Multiple Sclerosis: A systematic review.

Authors:  Angela Meggiolaro; Giuseppe Migliara; Giuseppe La Torre
Journal:  Hum Vaccin Immunother       Date:  2018-01-30       Impact factor: 3.452

5.  Human papillomavirus vaccine and systemic lupus erythematosus.

Authors:  Mariele Gatto; Nancy Agmon-Levin; Alessandra Soriano; Raffaele Manna; Ramit Maoz-Segal; Shaye Kivity; Andrea Doria; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2013-04-28       Impact factor: 3.650

6.  The two-faced T cell epitope: examining the host-microbe interface with JanusMatrix.

Authors:  Leonard Moise; Andres H Gutierrez; Chris Bailey-Kellogg; Frances Terry; Qibin Leng; Karim M Abdel Hady; Nathan C VerBerkmoes; Marcelo B Sztein; Phyllis T Losikoff; William D Martin; Alan L Rothman; Anne S De Groot
Journal:  Hum Vaccin Immunother       Date:  2013-04-12       Impact factor: 3.452

Review 7.  Occurrence of Autoimmune Diseases Related to the Vaccine against Yellow Fever.

Authors:  Ana Cristina Vanderley Oliveira; Licia Maria Henrique da Mota; Leopoldo Luiz Dos Santos-Neto; Jozélio Freire De Carvalho; Iramaya Rodrigues Caldas; Olindo Assis Martins Filho; Pedro Luis Tauil
Journal:  Autoimmune Dis       Date:  2014-10-22

Review 8.  Vaccines, adjuvants and autoimmunity.

Authors:  Luísa Eça Guimarães; Britain Baker; Carlo Perricone; Yehuda Shoenfeld
Journal:  Pharmacol Res       Date:  2015-08-12       Impact factor: 7.658

9.  Possible Triggering Effect of Influenza Vaccination on Psoriasis.

Authors:  Ali Tahsin Gunes; Emel Fetil; Sevgi Akarsu; Ozlem Ozbagcivan; Lale Babayeva
Journal:  J Immunol Res       Date:  2015-08-25       Impact factor: 4.818

Review 10.  Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety.

Authors:  Ronald N Kostoff; Darja Kanduc; Alan L Porter; Yehuda Shoenfeld; Daniela Calina; Michael B Briggs; Demetrios A Spandidos; Aristidis Tsatsakis
Journal:  Toxicol Rep       Date:  2020-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.